Dr. Scott Olson says lets look at the numbers:
The cost of taking care of yourself so that you don’t need these costly Rx’s just became obvious.  Now the cost of eating right, avoiding bad habits ie: smoking, overeating, lack of sleep etc. looks really affordable.  The cost of some of the following drugs come on the heals of a wallet draining premiums and deductibles.

The drug used to treat Hepatitis c costs $1,000 a pill in the USA  but just $10 in Egypt.

Almost overnight, Turing Pharmaceuticals raised the price for Daraprim, a treatment that fights life-threatening parasitic infections from $13.50 per pill to a whopping $750 a pill. The company’s mogul, Martin Shkreli, justified this drastic increase by saying that it’s simply about keeping business going strong, and he even went so far as to say that the increase doesn’t deserve the widespread criticism it is receiving.

When it comes to treating leukemia, it has been estimated that the actual cost for a year’s supply of Gleevec (generic name imatinib), is an affordable $159. However, in the United States, it costs people suffering with the illness more than $106,000 annually; in the United Kingdom, it costs more than $30,000 each year.

The insanity continues.

For example, other cancer-related treatments actually cost anywhere from a few hundred dollars to less than $5,000 annually. However, the sad reality is that the cost to consumers spikes outrageously; those few hundred dollars of drugs have been found to cost people in the United States upwards of $135,000 every year.

There’s even a new class of cholesterol-lowering drugs hitting the market that promise to lower levels by 60 percent. The catch? Compared to older statins that are said to do the same thing, these newer ones will cost a person approximately $14,000 annually. Some economists, who have taken the drugs’ unknown effectiveness and the role of insurance into consideration, say these newer statins should actually be priced at about 67 percent less.

We’re not done yet.

After an acquisition by Rodelis Therapeutics, Cycloserine, which helps treat multidrug-resistant tuberculosis, went from $500 for 30 pills to a whopping $10,800 for the same quantity.

On and on the price-gouging goes.

Americans are spending outrageous prices on prescription medications alone, most of which is brushed under the carpet by the drug companies. They maintain that it’s a necessary measure for their businesses to thrive, often citing the need to help pay for monies sunk into developing the drug in the first place. Drug companies also say that any action taken to lower the prices of certain drugs is an attack against them that would impede their ability to create new and improved drugs for Americans in need.

Putting price tags on pills that the average American can’t afford — especially when you consider other bills such as mortgages, loans, food and utilities that people have to pay — is only improving the health of drug companies’ bank accounts and nothing more.

Sources for this article include:
ZeroHedge.com
CommonHealth.WBUR.org
NYTimes.com